Merrimack Pharmaceuticals, Inc. MACK
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 223.97M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 100.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -8.50
- Beta
- 1.42
- Short ratio
- 8.65
- Inst. own
- 62.98%
- Dividend
- 15.10
- Ex-div date
- May 8, 2024
- Earnings
- May 15, 2024
- 50-d avg
- 14.84
- 200-d avg
- 13.48
- 1y target
- 0.00
Discussion (8)
Sign in to join the discussion
VICKY HANUKA MACK 2 years ago #1Buy buy buy before it’s to late buy and hold ???????????????
VICKY HANUKA MACK 2 years ago #2
VICKY HANUKA MACK 2 years ago #3US)
15.000
14.880
+7.22%
-0.80%
By Sabela Ojea
Merrimack Pharmaceuticals said it will receive a $225 million milestone payment from Ipsen after the U.S. Food and Drug Administration approved the supplemental new drug application for its pancreatic cancer treatment Onivydee.
The biopharmaceutical company on Tuesday said the payment is due on or before March 29.
The company has received several payments from Ipsen in the past, including a $575 million payment in 2017.
Sooon $HYLN
$MACK BOOM!!! ???
Sold my calls hope my puts play out next week
Carlos Monroy MACK 5 years ago #7$MACK - Down to 5.50 end of day. 4.30 by next Monday. This is absolutely pumped to be dumped!
Carlos Monroy MACK 5 years ago #8This will crack! Good luck you bulls!